If You Invested in Theriva Biologics Inc (SYN)
Looking for the current price? See the SYN quote & overviewWhat $1,000 or $10,000 in SYN Would Be Worth Now
Real historical value by amount invested and how long ago| If you invested | 1 year ago | 5 years ago | 10 years ago | Since Nov 2, 2015 |
|---|---|---|---|---|
| $1,000 | — | $235 -76% | $73 -93% | $43 -96% |
| $10,000 | — | $2,355 -76% | $729 -93% | $427 -96% |
Based on real historical closing prices adjusted for stock splits, without dividends, through 2022-10-12. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for SYN$1,000 Investment Over Time
SYN vs S&P 500Year-by-Year Returns
SYN annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2015 | $23.90 | $22.90 | -4.2% | -4.2% |
| 2016 | $22.90 | $7.63 | -66.7% | -68.1% |
| 2017 | $7.63 | $5.08 | -33.4% | -78.7% |
| 2018 | $5.08 | $5.60 | +10.2% | -76.6% |
| 2019 | $5.60 | $5.07 | -9.5% | -78.8% |
| 2020 | $5.07 | $3.83 | -24.4% | -84.0% |
| 2021 | $3.83 | $2.72 | -28.9% | -88.6% |
| 2022 | $2.72 | $1.02 | -62.5% | -95.7% |
About Theriva Biologics Inc
Healthcare
Similar Stocks
See how related companies performed
Frequently Asked Questions
Theriva Biologics Inc investment returns
How much would $1,000 invested in Theriva Biologics Inc be worth today?
If you invested $1,000 in Theriva Biologics Inc (SYN) 10 years ago on 2016-10-31, your investment would be worth $73 as of 2022-10-12, a -92.7% price return without dividends, growing at a compounded rate of -35.6% per year (CAGR).
Has Theriva Biologics Inc outperformed the S&P 500?
Over the past 10 years, SYN returned -92.7% compared to +262.1% for the S&P 500, underperforming the benchmark by 354.8 percentage points.
What is Theriva Biologics Inc's average annual return?
The compound annual growth rate (CAGR) of SYN’s share price over the past 10 years is -35.6%, without dividends. Individual years vary a great deal, and SYN’s best recent full year was 2018 (+10.2%) while the worst was 2016 (-66.7%).
For informational and educational purposes only, not investment advice.
